Dr Andreas Weinberger Rosen and Prof Ismail Gögenur discuss their AI-supported decision system for perioperative colorectal ...

Eli Lilly boasts a wide range of products that serve a vast number of therapeutic areas. LLY focuses primarily on ...

Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

Medical devices giant Medtronic Plc (NYSE:MDT) is scheduled to report its second-quarter fiscal year 2026 results on Tuesday, November 18. According to data from Benzinga Pro, analysts estimate ...

In the latest close session, Medtronic (MDT) was up +2.38% at $92.20. This change outpaced the S&P 500's 0.13% gain on the day. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq lost 0.22%.

Medtronic (MDT) closed the most recent trading day at $91.98, moving -1% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.03%. Elsewhere, the Dow ...

Medtronic has long been a committed dividend payer -- and grower. It's been turning itself around after a slump. There's plenty of reason to be optimistic. Spoiler: Your money wouldn't have grown much ...

Medtronic boasts strong free cash flow, stable dividends, and innovation focus, but faces macro headwinds, high debt, and competitive pressures. Recent strategic portfolio moves, including spin-offs ...

Medtronic plans diabetes unit spin-off via IPO and split-off Fiscal 2026 earnings forecast below Wall Street estimates Tariff impact on 2026 costs estimated at $200-$350 million May 21 (Reuters) - ...